AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Innoviva, Inc. Director's Dealing 2011

Feb 23, 2011

32090_dirs_2011-02-23_5b9d1c74-e7c6-49ab-a616-9c855007e6a7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2011-02-20

Reporting Person: Shafer Bradford J (Sr VP, Gen. Counsel, Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-20	Common Stock	F	3111	$22.50	Disposed	367063	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2750	Indirect
Common Stock	2750	Indirect
Common Stock	2750	Indirect
Common Stock	6451	Indirect

Footnotes

F1: Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.

F2: Shares held in trust for the benefit of the children of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.